跳至主要内容
临床试验/NCT02994225
NCT02994225已完成不适用

Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity

Gustave Roussy, Cancer Campus, Grand Paris1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年3月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Rate of identification

研究概览

简要总结

The initial standard treatment of breast cancer is surgery. Tumor involvement of lymph nodes is of paramount importance in the subsequent management of this cancer and surgery of invasive breast cancer (BC) involves axillary lymph node dissection (ALND). To preserve arm lymphatic drainage during ALND and avoid the risk of arm lymphedema, mapping the lymphatic drainage by axillary reverse mapping (ARM) has been developed. But oncological safety is uncertain.

The ARM procedure presented here uses indocyanine green (ICG) and fluorescence detection of draining lymphatics. The project aims to train surgeons to the technique and to identify predictive factors for metastatic ARM nodes in invasive BC using tumor and axillary pathological parameters to better select patients who would not require removal of the ARM node in the future

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult patients over 18 years of age
  • Preoperative diagnosis of Invasive breast cancer
  • Patient deemed for total mastectomy with axillary lymph node dissection (ALND)
  • Subject capable of giving informed consent and participating in the process of consent
  • Affiliated to the french social security

排除标准

  • Mastectomy without ALND
  • Previous ipsilateral axillary radiotherapy
  • Previous axillary surgery
  • Pregnant women as determined by urinary or serum beta human chorionic gonadotropin (hCG) within 72 hours of surgery
  • Breastfeeding
  • Allergy to indocyanine green
  • Patients with a known history of reaction to iodine or iodine-containing compounds.
  • No consent
  • Impaired capacity to make informed medical decisions
  • Patient on guardianship

研究组 & 干预措施

Study arm

Experimental

Subcutaneous injection (1 ml) of the indocyanine green into the ipsilateral upper extremity 10 min before the surgery.

Near Infra-red images acquisition is performed during surgery

干预措施: Indocyanine Green (Drug)

结局指标

主要结局

Rate of identification

时间窗: up to 30 days

To determine the Rate of identification of reverse axillary node using Indocyanine green (ICG) and near-infrared (NIR) imaging in invasive breast cancer that undergo total mastectomy and ALND.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验